Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: Identification of genes potentially related to epithelial-mesenchymal transition

Oncogene

Volumn 26, Issue 57, 2007, Pages 7859-7871

  Lien, H C ^a   Hsiao, Y H ^b,c   Lin, Y S ^d   Yao, Y T ^a   Juan, H F ^e   Kuo, W H ^a   Hung, Mien Chie ^f,g   Chang, K J ^a   Hsieh, F J ^a,e  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^c CHANG JUNG CHRISTIAN UNIVERSITY   (Taiwan)

^d Welgene Biotech Co Ltd   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^f CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Epithelial mesenchymal transition; Metaplastic carcinoma of breast; Oligonucleotide microarray

Indexed keywords

OSTEONECTIN; TRANSCRIPTION FACTOR SNAIL; VIMENTIN;

ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; EPITHELIUM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; GENOME; HUMAN; HUMAN CELL; HUMAN TISSUE; MESENCHYME CELL; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; UPREGULATION;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIUM; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MESODERM; MULTIGENE FAMILY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SARCOMA; TRANSCRIPTION FACTORS;

GASTROPODA;

EID: 37149040456     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210593     Document Type: Article

References (38)

1. Al Sayed AD, El Weshi AN, Tulbah AM, Rahal MM, Ezzat AA. (2006). Metaplastic carcinoma of the breast clinical presentation, treatment results and prognostic factors. Acta Oncol 45: 188-195.
2. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM et al. (2000). Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25: 25-29.
3. Barnes PJ, Boutilier R, Chiasson D, Rayson D. (2005). Metaplastic breast carcinoma: clinical-pathologic characteristics and HER2/neu expression. Breast Cancer Res Treat 91: 173-178.
4. Bilanges B, Varrault A, Basyuk E, Rodriguez C, Mazumdar A, Pantaloni C et al. (1999). Loss of expression of the candidate tumor suppressor gene ZAC in breast cancer cell lines and primary tumors. Oncogene 18: 3979-3988.
5. Bundy LM, Sealy L. (2003). CCAAT/enhancer binding protein beta (C/EBPbeta)-2 transforms normal mammary epithelial cells and induces epithelial to mesenchymal transition in culture. Oncogene 22: 869-883.
6. Carter MR, Hornick JL, Lester S, Fletcher CD. (2006). Spindle cell (sarcomatoid) carcinoma of the breast: a clinicopathologic and immunohistochemical analysis of 29 cases. Am J Surg Pathol 30: 300-309.
7. Doane AS, Danso M, Lal P, Donaton M, Zhang L, Hudis C et al. (2006). An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen. Oncogene 25: 3994-4008.
8. Doege KJ, Sasaki M, Kimura T, Yamada Y. (1991). Complete coding sequence and deduced primary structure of the human cartilage large aggregating proteoglycan, aggrecan. Human-specific repeats, and additional alternatively spliced forms. J Biol Chem 266: 894-902.
9. Framson PE, Sage EH. (2004). SPARC and tumor growth: where the seed meets the soil? J Cell Biochem 92: 679-690.
10. Fujiwara S, Takeo N, Otani Y, Parry DA, Kunimatsu M, Lu R et al. (2001). Epiplakin, a novel member of the Plakin family originally identified as a 450-kDa human epidermal autoantigen. Structure and tissue localization. J Biol Chem 276: 13340-13347.
11. Gersch RP, Lombardo F, McGovern SC, Hadjiargyrou M. (2005). Reactivation of Hox gene expression during bone regeneration. J Orthop Res 23: 882-890.
12. Jansen S, Stefan C, Creemers JW, Waelkens E, Van Eynde A, Stalmans W et al. (2005). Proteolytic maturation and activation of autotaxin (NPP2), a secreted metastasis-enhancing lysophospholipase D. J Cell Sci 118: 3081-3089.
13. Jechlinger M, Sommer A, Moriggl R, Seither P, Kraut N, Capodiecci P et al. (2006). Autocrine PDGFR signaling promotes mammary cancer metastasis. J Clin Invest 116: 1561-1570.
14. Jones C, Mackay A, Grigoriadis A, Cossu A, Reis-Filho JS, Fulford L et al. (2004). Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer. Cancer Res 64: 3037-3045.
15. Korsching E, Packeisen J, Liedtke C, Hungermann D, Wulfing P, van Diest PJ et al. (2005). The origin of vimentin expression in invasive breast cancer: epithelial-mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential? J Pathol 206: 451-457.
16. Kusafuka K, Ishiwata T, Sugisaki Y, Takemura T, Kusafuka M, Hisha H et al. (2004). Lumican expression is associated with the formation of mesenchyme-like elements in salivary pleomorphic adenomas. J Pathol 203: 953-960.
17. Lee JM, Dedhar S, Kalluri R, Thompson EW. (2006). The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 172: 973-981.
18. Lemmers C, Michel D, Lane-Guermonprez L, Delgrossi MH, Medina E, Arsanto JP et al. (2004). CRB3 binds directly to Par6 and regulates the morphogenesis of the tight junctions in mammalian epithelial cells. Mol Biol Cell 15: 1324-1333.
19. Lien HC, Lin CW, Mao TL, Kuo SH, Hsiao CH, Huang CS. (2004). p53 overexpression and mutation in metaplastic carcinoma of the breast: genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components. J Pathol 204: 131-139.
20. Liu Y, Nusrat A, Schnell FJ, Reaves TA, Walsh S, Pochet M et al. (2000). Human junction adhesion molecule regulates tight junction resealing in epithelia. J Cell Sci 113: 2363-2374.
21. Ma L, Lu MF, Schwartz RJ, Martin JF. (2005). Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning. Development 132: 5601-5611.
22. Oehler MK, Fischer DC, Orlowska-Volk M, Herrle F, Kieback DG, Rees MC et al. (2003). Tissue and plasma expression of the angiogenic peptide adrenomedullin in breast cancer. Br J Cancer 89: 1927-1933.
23. Pezzi CM, Patel-Parekh L, Cole K, Franko J, Klimberg VS, Bland K. (2007). Characteristics and treatment of metaplastic breast cancer: analysis of 892 cases from the national cancer data base. Ann Surg Oncol 14: 166-173.
24. Pfister BE, Aydelotte MB, Burkhart W, Kuettner KE, Schmid TM. (2001). Del1: a new protein in the superficial layer of articular cartilage. Biochem Biophys Res Commun 286: 268-273.
25. Reinholz MM, Iturria SJ, Ingle JN, Roche PC. (2002). Differential gene expression of TGF-beta family members and osteopontin in breast tumor tissue: analysis by real-time quantitative PCR. Breast Cancer Res Treat 74: 255-269.
26. Reis-Filho JS, Milanezi F, Paredes J, Silva P, Pereira EM, Maeda SA et al. (2003). Novel andclassic myoepithelial/stem cell markers in metaplastic carcinomas of the breast. Appl Immunohistochem Mol Morphol 11: 1-8.
27. Rosai J. (2004). Rosai and Ackerman's Surgical Pathology. St Louis: Mosby, pp 1828-1829.
28. Ryoo HM, Lee MH, Kim YJ. (2006). Critical molecular switches involved in BMP-2-induced osteogenic differentiation of mesenchymal cells. Gene 366: 51-57.
29. Saika S, Miyamoto T, Tanaka S, Tanaka T, Ishida I, Ohnishi Y et al. (2003). Response of lens epithelial cells to injury: role of lumican in epithelial-mesenchymal transition. Invest Ophthalmol Vis Sci 44: 2094-2102.
30. Siddiq F, Sarkar FH, Wali A, Pass HI, Lonardo F. (2004). Increased osteonectin expression is associated with malignant transformation and tumor associated fibrosis in the lung. Lung Cancer 45: 197-205.
31. Soda H, Raymond E, Sharma S, Lawrence R, Cerna C, Gomez L et al. (1998). Antiproliferative effects of recombinant human bone morphogenetic protein-2 on human tumor colony-forming units. Anticancer Drugs 9: 327-331.
32. Stanton H, Rogerson FM, East CJ, Golub SB, Lawlor KE, Meeker CT et al. (2005). ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 434: 648-652.
33. Thiery JP. (2002). Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454.
34. Wilson CA, Dering J. (2004). Recent translational research: microarray expression profiling of breast cancer - beyond classification and prognostic markers? Breast Cancer Res 6: 192-200.
35. Xu X, Bringas Jr P, Soriano P, Chai Y. (2005). PDGFR-alpha signaling is critical for tooth cusp and palate morphogenesis. Dev Dyn 232: 75-84.
36. Zavadil J, Bottinger EP. (2005). TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 24: 5764-5774.
37. Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M et al. (2004). Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 6: 931-940.
38. Zhuang Z, Lininger RA, Man YG, Albuquerque A, Merino MJ, Tavassoli FA. (1997). Identical clonality of both components of mammary carcinosarcoma with differential loss of heterozygosity. Mod Pathol 10: 354-362.